5mg · Purity & Identity · New Batch
- Batch
- AOD0589CP
- Test date
- 2026-11-05

5mg
❄️Lyophilized powder (not reconstituted)
Total: 36.66 GBP
Discount per Quantity
| Quantity | Discount | Price per Unit |
|---|---|---|
| 5 - 9 | 10% | 32.99 GBP |
| 10 - 19 | 20% | 29.33 GBP |
| 20+ | 30% | 25.66 GBP |
Rigorous third-party testing
Every batch of our research chemicals and peptides undergoes independent third-party laboratory testing for purity and identity.
Total: 36.66 GBP
Order within 12h 31m 02s · ships today
Cutoff 3:00 PM EET
Arrives Thu, Nov 12 – Mon, Nov 16
Free shipment protection
Lost or damaged parcels are replaced — refunded in full if a second one fails
Express 1–3 day delivery
Available at checkout
AOD-9604 is supplied as a catalogued research material in 5 mg.
AOD-9604 is a defined 16-residue disulfide peptide, more precisely Tyr-hGH(177–191). The common “HGH Fragment 176–191” label should not be treated as proof that the material is the unmodified native fragment [1,2].
| Property | Value |
|---|---|
| Name and synonyms | AOD-9604; Tyr-hGH(177–191); commonly marketed as HGH Fragment 176–191 |
| Material category | Synthetic cyclic disulfide analogue of a C-terminal human growth-hormone fragment; research peptide |
| Sequence or structural definition | H-Tyr-Leu-Arg-Ile-Val-Gln-Cys(1)-Arg-Ser-Val-Glu-Gly-Ser-Cys(1)-Gly-Phe-OH; YLRIVQCRSVEGSCGF |
| Molecular formula | C78H123N23O23S2 for the free cyclic peptide; salts and solvates differ. |
| Average molecular mass | 1815.1 g/mol average mass for the free cyclic peptide. |
| CAS Registry Number | 221231-10-3 for the free cyclic peptide, conditional on exact-form confirmation. |
| PubChem CID | CID 71300630 for the free cyclic peptide, conditional on exact-form confirmation. |
| Structural features | 16 residues with a Cys7–Cys14 intramolecular disulfide; N-terminal Tyr replaces the Phe present in native hGH(176–191). |
| Appearance | White to off-white lyophilised powder. |
| Solubility | Highly hydrophobic. Reconstitute with 0.6% acetic acid water; not readily soluble in plain bacteriostatic or sterile water. |
| Physical form | Catalogue vial; the exact physical state, salt or counter-ion and excipients are batch-specific and must be verified in the CoA and SDS. |
| Catalogue presentations | 5 mg |
| Batch identity and quality documentation | Lot-specific identity and available analytical reports must be verified against the CoA entry associated with the exact product size and batch. |
Registry values apply only to the matching sequence or structure and exact material form. Confirm terminal modifications, conjugation, salt or counter-ion and hydration against the batch CoA and SDS; batch records take precedence over literature identifiers.
Published work has examined AOD-9604 and related C-terminal hGH fragments in structural, metabolic and analytical research models [2,3].
The FDA review identified limited human evidence, no human pharmacokinetic data and no established clinical efficacy. Those publications do not authenticate this catalogue batch or support human use [2].
AOD-9604, native hGH(176–191), acetate salts and other fragment analogues are analytically distinct materials.
| Aspect | This catalogue material | Comparator |
|---|---|---|
| Identity | AOD-9604: cyclic Tyr-hGH(177–191), conditional on batch confirmation | Native hGH(176–191) C-terminal fragment |
| Structural distinction | Tyr at the N terminus and a defined Cys7–Cys14 disulfide | Phe at the corresponding N-terminal position of the native 176–191 fragment |
| Analytical implication | Confirm intact mass, disulfide connectivity, termini and counter-ion | Sequence-specific analysis must distinguish the N-terminal Phe/Tyr substitution |
Quality information is batch- and presentation-specific. Use only the report linked to the exact size and lot. A report listed for another size, lot or similarly named material must not be treated as evidence for this product.
Chromatographic area purity, identity, net peptide or analyte content, water or counter-ion content, sterility, endotoxin and elemental impurities are different measurements. One result does not establish the others. Only tests supported by a visible, matching report should be regarded as available.
Store and handle only under the conditions stated on the product label, batch CoA and SDS. Keep the container secured, correctly identified and protected from contamination. Do not infer storage, solvent compatibility or stability from a related compound.
Laboratory preparation, analytical-method selection, risk assessment, personal protective equipment and waste disposal should follow the applicable SDS and the institution's approved procedures.
| Research-use notice | This material is supplied exclusively for laboratory research by qualified professionals and is not intended for human or veterinary use. Purchasers are responsible for compliance with applicable local requirements. |
Only when the exact sequence or structure, termini, conjugation, salt or counter-ion and hydration state match. The batch CoA and SDS govern; a related-compound identifier must not be substituted.
It is method- and report-specific. For example, an HPLC area percentage is not automatically the same as identity, net content, sterility, endotoxin status or absence of elemental impurities.
Follow the exact label, batch CoA and SDS together with the institution's risk assessment. Use only storage and stability information linked to the exact material form and batch.
This site does not provide medical advice. These statements have not been evaluated by the FDA or the European Medicines Agency (EMA). Products are not drugs and are not intended to diagnose, treat, cure, or prevent any disease.
Enter your email to receive promo codes, special offers and the latest updates.
Occasional emails only. Unsubscribe anytime.